pyrazines has been researched along with tosylphenylalanyl chloromethyl ketone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, J; Buckley, M; Elliott, PJ; Jiang, JD; Liebes, L; Ling, YH; Muggia, FM; Ng, B; Perez-Soler, R | 1 |
| Liebes, L; Ling, YH; Muggia, F; Perez-Soler, R; Piperdi, B | 1 |
2 other study(ies) available for pyrazines and tosylphenylalanyl chloromethyl ketone
| Article | Year |
|---|---|
PS-341, a novel proteasome inhibitor, induces Bcl-2 phosphorylation and cleavage in association with G2-M phase arrest and apoptosis.
Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; Blotting, Western; Boronic Acids; Bortezomib; Cell Line; Cysteine Endopeptidases; DNA Fragmentation; Flow Cytometry; G2 Phase; Humans; Mitosis; Models, Biological; Multienzyme Complexes; Phosphorylation; Protease Inhibitors; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Subcellular Fractions; Time Factors; Tosylphenylalanyl Chloromethyl Ketone; Tumor Cells, Cultured | 2002 |
Bortezomib: understanding the mechanism of action.
Topics: Antineoplastic Agents; Apoptosis; Boronic Acids; Humans; Multienzyme Complexes; Protease Inhibitors; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Tosylphenylalanyl Chloromethyl Ketone | 2011 |